首页> 美国卫生研究院文献>DARU Journal of Pharmaceutical Sciences >Worldwide legislative challenges related to psychoactive drugs
【2h】

Worldwide legislative challenges related to psychoactive drugs

机译:与精神药物有关的全球立法挑战

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AbstractThe discovery of a “new” psychoactive substance is a relatively exceptional event, while the regulatory response usually involved the assessment of risks to public health and inclusion of the novel substance in the national list of controlled substances. However, in recent years we have witnessed the rapid emergence of new chemical substances, which elude international control and pose a challenge to existing processes and a threat to the credibility of control systems. We currently review and present characteristics of these legal and illegal new substances and issues regarding their global monitoring and regulatory measures already taken, or in the process of being taken, for their control. The concept of prohibition applied in active substance-related legislation is rather hazard ridden as balance is required between the ban on substances of potential therapeutic use and the access on the market of high-risk substances.
机译:摘要发现一种“新型”精神活性物质是一个相对特殊的事件,而监管对策通常涉及对公众健康的风险评估以及将该新型物质列入国家受控物质清单。但是,近年来,我们目睹了新兴的化学物质的迅速出现,这些化学物质无法进行国际管制,对现有工艺构成了挑战,并威胁到控制系统的信誉。我们目前正在审查并介绍这些合法和非法新物质的特性,以及有关已经为控制它们而已采取或正在采取的全球监视和监管措施的问题。与活性物质有关的立法中所采用的禁止概念相当危险,因为在潜在治疗用途的禁令与高风险物质的市场准入之间需要取得平衡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号